KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E Adjustments
Ratios

TherapeuticsMD (TXMD) Depreciation Expense (2018 - 2023)

Historic Depreciation Expense for TherapeuticsMD (TXMD) over the last 7 years, with Q4 2023 value amounting to -$185000.0.

  • TherapeuticsMD's Depreciation Expense rose 3485.92% to -$185000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $100000.0, marking a year-over-year decrease of 8333.33%. This contributed to the annual value of $100000.0 for FY2023, which is 8333.33% down from last year.
  • According to the latest figures from Q4 2023, TherapeuticsMD's Depreciation Expense is -$185000.0, which was up 3485.92% from $130000.0 recorded in Q3 2023.
  • TherapeuticsMD's Depreciation Expense's 5-year high stood at $329000.0 during Q1 2022, with a 5-year trough of -$284000.0 in Q4 2022.
  • Its 3-year average for Depreciation Expense is $85172.9, with a median of $128000.0 in 2023.
  • Its Depreciation Expense has fluctuated over the past 5 years, first surged by 6321.95% in 2019, then tumbled by 9179.33% in 2023.
  • TherapeuticsMD's Depreciation Expense (Quarter) stood at $66556.0 in 2019, then tumbled by 526.71% to -$284000.0 in 2022, then skyrocketed by 34.86% to -$185000.0 in 2023.
  • Its last three reported values are -$185000.0 in Q4 2023, $130000.0 for Q3 2023, and $128000.0 during Q2 2023.